11Syndromic Deafness

FWhy a syndromic label changes the plan

A syndromic diagnosis predicts the natural history of the hearing loss, the likely inner-ear anatomy, and coexisting medical risks that the implant pathway must accommodate. The same label can shift the timing of surgery in opposite directions, toward urgency when vision is also failing, or toward extra preoperative work-up when a cardiac or airway risk must first be cleared. Genetic confirmation increasingly informs counselling on progression, the second ear, and family recurrence, and is part of modern candidacy assessment. Most syndromic deafness is still cochlear and still implantable; the syndrome modifies how and when, not usually whether. Coordination with cardiology, ophthalmology, genetics and anaesthesia is the practical signature of syndromic cases.[2009][2005]

CUsher syndrome: racing the eyes

Usher syndrome combines sensorineural hearing loss with progressive retinitis pigmentosa, so the child faces a dual sensory loss in which hearing must be secured before vision deteriorates and reliance on it grows. Type 1 brings profound congenital deafness with vestibular areflexia and early visual decline, making the argument for very early implantation strongest in this group. Because the cochlea and auditory nerve are typically intact, auditory outcomes after implantation are generally good, and early-implanted children can approach the trajectory of non-syndromic peers. In types 2 and 3, where some usable acoustic hearing often persists, favourable outcomes are expected particularly when there has been good prior amplification and auditory stimulation. The deaf-blind risk reframes counselling: restoring one reliable sensory channel early is a long-term investment in independence and communication.[2024][2005]

TPendred, EVA, Waardenburg and BOR

Pendred syndrome links sensorineural loss, goitre and bilateral enlarged vestibular aqueduct, with cochleae that commonly show an incomplete-partition pattern; the hearing loss is characteristically fluctuating and progressive. Despite the malformed anatomy, electrode insertion is usually achievable and audiological outcomes are favourable, so EVA and Pendred are good implant indications rather than barriers. Enlarged vestibular aqueduct raises the chance of a perilymph gusher at cochleostomy, so the surgeon plans for fluid control and the family is warned of step-wise drops in residual hearing. Waardenburg syndrome (pigmentary changes with sensorineural deafness) generally has a normally formed cochlea and yields outcomes comparable to non-syndromic recipients. Branchio-oto-renal syndrome pairs ear malformations and hearing loss with branchial and renal anomalies, so preoperative assessment of inner-ear anatomy and renal function is part of planning.[2021][2009]

CJervell and Lange-Nielsen and CHARGE: safety first

Jervell and Lange-Nielsen syndrome combines profound congenital deafness with the long-QT phenotype, predisposing to torsades de pointes, syncope and sudden death; about 90 percent of cases involve KCNQ1. A preoperative ECG is mandatory in any child with profound deafness and a suggestive history, because surgical stress and several anaesthetic agents can trigger fatal arrhythmia, including after the operation ends. Safe implantation requires cardiology co-management, beta-blockade, avoidance of QT-prolonging drugs, and consideration of an implantable defibrillator; an existing pacemaker does not contraindicate the implant. CHARGE syndrome contributes aberrant temporal-bone anatomy, frequent cochlear nerve deficiency, and cardiac and airway risks, so it sits at the intersection of surgical difficulty and medical fragility. Across these syndromes the lesson is identical: clear the medical risk first, then implant, the audiological benefit is only realised if the child is brought safely through anaesthesia.[2015][2022]